“Cost Evaluation and Economic Sustainability of Enzyme Replacement Therapies for Fabry Disease in Italy from the Hospital Perspective” (2025) Farmeconomia. Health Economics and Therapeutic Pathways, 26(1). doi:10.7175/fe.v26i1.1582.